Additionally, previous studies showing that diacerein, a widely used IL-1-targeted OA symptomatic drug, alleviates periodontitis-induced gingival mucosa inflammation in rats and reduces MMP8 expression via IL-1β inhibition may partially explain the correlation between RJ’s MMP8 inhibition and OA symptomatic relief observed in this study [64]. This evidence concerns the gene IL1B and periodontitis.